Authors/Disclosures
|
Kimford J. Meador, MD, FAAN
(Stanford University School of Medicine)
|
The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium. |
|
Neil W. Thomas, MD
(Bruyere Memory Program)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Anne E. Hammer
(Glaxo Welcome)
|
No disclosure on file |
|
|
No disclosure on file |
|
Mitchell Miller, PharmD
(GlaxoSmithKline)
|
No disclosure on file |
|
Luiz H. Castro, MD
(University of Sao Paulo)
|
Dr. Castro has nothing to disclose. |
|
Hiroko H. Dodge, PhD
(Massachusetts General Hospital)
|
No disclosure on file |
|
Lisa Silbert, MD, FAAN
(OHSU)
|
The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH. |
|
Jeffrey A. Kaye, MD, FAAN
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
|
Deniz Erten-Lyons, MD, FAAN
(FDA)
|
Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |